Close

SCP2

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This gene encodes two proteins: sterol carrier protein X (SCPx) and sterol carrier protein 2 (SCP2), as a result of transcription initiation from 2 independently regulated promoters. The transcript initiated from the proximal promoter encodes the longer SCPx protein, and the transcript initiated from the distal promoter encodes the shorter SCP2 protein, with the 2 proteins sharing a common C-terminus. Evidence suggests that the SCPx protein is a peroxisome-associated thiolase that is involved in the oxidation of branched chain fatty acids, while the SCP2 protein is thought to be an intracellular lipid transfer protein. This gene is highly expressed in organs involved in lipid metabolism, and may play a role in Zellweger syndrome, in which cells are deficient in peroxisomes and have impaired bile acid synthesis. Alternative splicing of this gene produces multiple transcript variants, some encoding different isoforms.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ2045 Anti-SCP2 (CBXS-3973) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-3973 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2046 Anti-SCP2 (CBXS-4061) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4061 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2047 Anti-SCP2 (CBXS-4898) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4898 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2048 Anti-SCP2 (CBXS-4937) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-4937 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2049 Anti-SCP2 (CBXS-1622) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse, Rat, Human CBXS-1622 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ2050 Anti-SCP2 (CBXS-2900) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXS-2900 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5469 Anti-SCP2 (CBXS-3973) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-3973 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5470 Anti-SCP2 (CBXS-4061) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4061 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5471 Anti-SCP2 (CBXS-4898) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4898 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5472 Anti-SCP2 (CBXS-4937) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-4937 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5473 Anti-SCP2 (CBXS-1622) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse, Rat, Human CBXS-1622 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ5474 Anti-SCP2 (CBXS-2900) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXS-2900 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.